CASSIN, RAMONA

CASSIN, RAMONA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 33 (tempo di esecuzione: 0.005 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 2023 Andrea LombardiGiulia VieroSimone VillaEmanuele PalombaCecilia Azzara'Nathalie IannottiCamilla GenoveseMara TomaselloAnna TonizzoMarco FavaLetizia MorlacchiGiuseppe CastellanoRamona CassinMaria CarrabbaAndrea GoriAlessandra Bandera + Article (author) -
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 2023 Andrea LombardiGiulia VieroSimone VillaEmanuele PalombaNathalie IannottiCamilla GenoveseMara TomaselloAnna TonizzoMarco FavaLetizia Corinna MorlacchiGiuseppe CastellanoRamona CassinMaria CarrabbaAndrea GoriAlessandra Bandera + Article (author) -
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study 2022 Simone VillaCamilla GenoveseMara TomaselloAnna TonizzoMarco FavaNathalie IannottiMatteo BolisLetizia Corinna MorlacchiGiuseppe CastellanoRamona CassinMaria CarrabbaANDREA GORIAlessandra BanderaAndrea Lombardi + Article (author) -
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 2021 Reda G.Zucchetto A.Cassin R.Neri A. + Article (author) -
Lymphocytic infiltrate and p53 protein expression as predictive markers of response and outcome in myelodysplastic syndromes treated with azacitidine 2021 Pescia C.Croci G. A.Cassin R.Barella M.Pettine L.Reda G.Sabattini E.Gianelli U. + Article (author) -
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine. Results of study on 486 cases outside clinical trials 2021 Reda, GianluigiZucchetto, AntonellaCassin, RamonaNeri, Antonino + Article (author) -
Assessment of the 4-factor score : Retrospective analysis of 586 CLL patients receiving ibrutinib : A campus CLL study 2021 Reda G.Zucchetto A.Cassin R.Neri A. + Article (author) -
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome 2021 Fattizzo B.Cassin R.Patriarca A. + Article (author) -
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 2020 Fattizzo, BrunoGiannotta, Juri AlessandroBarbanti, Maria ChiaraBucelli, CristinaCassin, RamonaCattaneo, DanieleCavallaro, FrancescaFerla, ValeriaFracchiolla, Nicola StefanoMattiello, VeronicaNeri, AntoninoNoto, AlessandroOnida, FrancescoPasquale, RaffaellaPettine, LoredanaReda, GianluigiRossi, Francesca GaiaSaporiti, Giorgia NatasciaSciumè, MariaritaBaldini, Luca + Article (author) -
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL) 2019 Cassin, RMattiello, VGianelli, UNeri, ACortelezzi, AReda, G + Article (author) -
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia 2019 Reda, GCassin, RFattizzo, BBarbieri, MSilvestris, IFabris, SNeri, ACortelezzi, A + Article (author) -
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome : From Megakaryopoiesis to Immunomodulation 2019 Fattizzo B.Levati G.Cassin R. + Article (author) -
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia 2018 G. RedaR. CassinA. ArtoniB. FattizzoA. LecchiS. La MarcaP. BucciarelliG. V. LevatiF. PeyvandiA. Cortelezzi Article (author) -
Predictors of atrial fibrillation in ibrutinib-treated CLL patients : a prospective study 2018 Reda G.Fattizzo B.Cassin R.Mattiello V.Tonella T.Cortelezzi A. + Article (author) -
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia 2018 Reda G.Fattizzo B.Cassin R.Pennisi M.Cairoli R.Cortelezzi A. + Article (author) -
Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice? 2017 Gianluigi RedaRamona CassinVeronica MattielloTatiana TonellaBruno FattizzoFrancesco OnidaAgostino Cortelezzi + Article (author) -
Biological and molecular characterization of a rare case of cutaneous Richter syndrome 2017 G. RedaR. CassinS. FabrisG. CiceriB. FattizzoM. SciumèN. OrofinoU. GianelliA. NeriA. Cortelezzi Article (author) -
Hypogammaglobulinemia is a strong predictor of time to first treatment in chronic lymphocytic leukemia 2017 G. RedaR. CassinG. V. LevatiB. FattizzoV. MattielloA. Cortelezzi + Article (author) -
Chronic lymphocytic leukemia and prognostic models : a bridge between clinical and biological markers 2017 G. RedaR. CassinB. FattizzoV. MattielloA. Cortelezzi + Article (author) -
Hypogammaglobulinemia in Chronic Lymphocytic Leukemia: A Predictor of Outcome? 2017 Gianluigi RedaRamona CassinGiorgia LevatiBruno FattizzoVeronica MattielloFrancesco OnidaAgostino Cortelezzi + Article (author) -